Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Clinical Next Generation Sequencing (NGS) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4522238
    • |
  • 14 March, 2023
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Clinical Next Generation Sequencing (NGS) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Clinical Next Generation Sequencing (NGS) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Clinical Next Generation Sequencing (NGS) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Clinical Next Generation Sequencing (NGS)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Clinical Next Generation Sequencing (NGS) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Illumina, Thermo Fisher Scientific, Eurofins Scientific and BGI Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Clinical Next Generation Sequencing (NGS) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sequencing by Synthesis (SBS)
Nanopore Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Others
Market segment by Application
Diagnostics
Drug Discovery & Designing
Medical Research
Others
Market segment by players, this report covers
Agilent Technologies
Illumina
Thermo Fisher Scientific
Eurofins Scientific
BGI Group
Qiagen
Roche Diagnostics
Bio-Rad
Congenica
Theragen Etex
PerkinElmer
Partek
Oxford Nanopore Technologies
Pacific Biosciences of California
Golden Helix
BioDatomics
PierianDx
DNAStar
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Clinical Next Generation Sequencing (NGS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Clinical Next Generation Sequencing (NGS), with revenue, gross margin and global market share of Clinical Next Generation Sequencing (NGS) from 2018 to 2023.
Chapter 3, the Clinical Next Generation Sequencing (NGS) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Clinical Next Generation Sequencing (NGS) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Next Generation Sequencing (NGS).
Chapter 13, to describe Clinical Next Generation Sequencing (NGS) research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Clinical Next Generation Sequencing (NGS)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Clinical Next Generation Sequencing (NGS) by Type
    • 1.3.1 Overview: Global Clinical Next Generation Sequencing (NGS) Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type in 2022
    • 1.3.3 Sequencing by Synthesis (SBS)
    • 1.3.4 Nanopore Sequencing
    • 1.3.5 Single-Molecule Real-Time (SMRT) Sequencing
    • 1.3.6 Others
  • 1.4 Global Clinical Next Generation Sequencing (NGS) Market by Application
    • 1.4.1 Overview: Global Clinical Next Generation Sequencing (NGS) Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Diagnostics
    • 1.4.3 Drug Discovery & Designing
    • 1.4.4 Medical Research
    • 1.4.5 Others
  • 1.5 Global Clinical Next Generation Sequencing (NGS) Market Size & Forecast
  • 1.6 Global Clinical Next Generation Sequencing (NGS) Market Size and Forecast by Region
    • 1.6.1 Global Clinical Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Clinical Next Generation Sequencing (NGS) Market Size by Region, (2018-2029)
    • 1.6.3 North America Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
    • 1.6.6 South America Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Agilent Technologies
    • 2.1.1 Agilent Technologies Details
    • 2.1.2 Agilent Technologies Major Business
    • 2.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.1.4 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Agilent Technologies Recent Developments and Future Plans
  • 2.2 Illumina
    • 2.2.1 Illumina Details
    • 2.2.2 Illumina Major Business
    • 2.2.3 Illumina Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.2.4 Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Illumina Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific
    • 2.3.1 Thermo Fisher Scientific Details
    • 2.3.2 Thermo Fisher Scientific Major Business
    • 2.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.4 Eurofins Scientific
    • 2.4.1 Eurofins Scientific Details
    • 2.4.2 Eurofins Scientific Major Business
    • 2.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.4.4 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.5 BGI Group
    • 2.5.1 BGI Group Details
    • 2.5.2 BGI Group Major Business
    • 2.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.5.4 BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 BGI Group Recent Developments and Future Plans
  • 2.6 Qiagen
    • 2.6.1 Qiagen Details
    • 2.6.2 Qiagen Major Business
    • 2.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.6.4 Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Qiagen Recent Developments and Future Plans
  • 2.7 Roche Diagnostics
    • 2.7.1 Roche Diagnostics Details
    • 2.7.2 Roche Diagnostics Major Business
    • 2.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.7.4 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.8 Bio-Rad
    • 2.8.1 Bio-Rad Details
    • 2.8.2 Bio-Rad Major Business
    • 2.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.8.4 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Bio-Rad Recent Developments and Future Plans
  • 2.9 Congenica
    • 2.9.1 Congenica Details
    • 2.9.2 Congenica Major Business
    • 2.9.3 Congenica Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.9.4 Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Congenica Recent Developments and Future Plans
  • 2.10 Theragen Etex
    • 2.10.1 Theragen Etex Details
    • 2.10.2 Theragen Etex Major Business
    • 2.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.10.4 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Theragen Etex Recent Developments and Future Plans
  • 2.11 PerkinElmer
    • 2.11.1 PerkinElmer Details
    • 2.11.2 PerkinElmer Major Business
    • 2.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.11.4 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 PerkinElmer Recent Developments and Future Plans
  • 2.12 Partek
    • 2.12.1 Partek Details
    • 2.12.2 Partek Major Business
    • 2.12.3 Partek Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.12.4 Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Partek Recent Developments and Future Plans
  • 2.13 Oxford Nanopore Technologies
    • 2.13.1 Oxford Nanopore Technologies Details
    • 2.13.2 Oxford Nanopore Technologies Major Business
    • 2.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.13.4 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Oxford Nanopore Technologies Recent Developments and Future Plans
  • 2.14 Pacific Biosciences of California
    • 2.14.1 Pacific Biosciences of California Details
    • 2.14.2 Pacific Biosciences of California Major Business
    • 2.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.14.4 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Pacific Biosciences of California Recent Developments and Future Plans
  • 2.15 Golden Helix
    • 2.15.1 Golden Helix Details
    • 2.15.2 Golden Helix Major Business
    • 2.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.15.4 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Golden Helix Recent Developments and Future Plans
  • 2.16 BioDatomics
    • 2.16.1 BioDatomics Details
    • 2.16.2 BioDatomics Major Business
    • 2.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.16.4 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 BioDatomics Recent Developments and Future Plans
  • 2.17 PierianDx
    • 2.17.1 PierianDx Details
    • 2.17.2 PierianDx Major Business
    • 2.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.17.4 PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 PierianDx Recent Developments and Future Plans
  • 2.18 DNAStar
    • 2.18.1 DNAStar Details
    • 2.18.2 DNAStar Major Business
    • 2.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Product and Solutions
    • 2.18.4 DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 DNAStar Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Clinical Next Generation Sequencing (NGS) Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Clinical Next Generation Sequencing (NGS) by Company Revenue
    • 3.2.2 Top 3 Clinical Next Generation Sequencing (NGS) Players Market Share in 2022
    • 3.2.3 Top 6 Clinical Next Generation Sequencing (NGS) Players Market Share in 2022
  • 3.3 Clinical Next Generation Sequencing (NGS) Market: Overall Company Footprint Analysis
    • 3.3.1 Clinical Next Generation Sequencing (NGS) Market: Region Footprint
    • 3.3.2 Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
    • 3.3.3 Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Clinical Next Generation Sequencing (NGS) Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
  • 6.2 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
  • 6.3 North America Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 6.3.1 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
    • 6.3.2 United States Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
  • 7.2 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
  • 7.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 7.3.1 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 7.3.3 France Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Clinical Next Generation Sequencing (NGS) Market Size by Region
    • 8.3.1 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2029)
    • 8.3.2 China Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 8.3.5 India Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
  • 9.2 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
  • 9.3 South America Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 9.3.1 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Country
    • 10.3.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Clinical Next Generation Sequencing (NGS) Market Drivers
  • 11.2 Clinical Next Generation Sequencing (NGS) Market Restraints
  • 11.3 Clinical Next Generation Sequencing (NGS) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Clinical Next Generation Sequencing (NGS) Industry Chain
  • 12.2 Clinical Next Generation Sequencing (NGS) Upstream Analysis
  • 12.3 Clinical Next Generation Sequencing (NGS) Midstream Analysis
  • 12.4 Clinical Next Generation Sequencing (NGS) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Clinical Next Generation Sequencing (NGS). Industry analysis & Market Report on Clinical Next Generation Sequencing (NGS) is a syndicated market report, published as Global Clinical Next Generation Sequencing (NGS) Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Clinical Next Generation Sequencing (NGS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo